412 related articles for article (PubMed ID: 36875849)
21. Fighting Fatty Liver Diseases with Nutritional Interventions, Probiotics, Symbiotics, and Fecal Microbiota Transplantation (FMT).
Nobili V; Mosca A; Alterio T; Cardile S; Putignani L
Adv Exp Med Biol; 2019; 1125():85-100. PubMed ID: 30578461
[TBL] [Abstract][Full Text] [Related]
22. Mechanistic and physiological approaches of fecal microbiota transplantation in the management of NAFLD.
Gupta M; Krishan P; Kaur A; Arora S; Trehanpati N; Singh TG; Bedi O
Inflamm Res; 2021 Jul; 70(7):765-776. PubMed ID: 34212214
[TBL] [Abstract][Full Text] [Related]
23. Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol.
Lambert JE; Parnell JA; Eksteen B; Raman M; Bomhof MR; Rioux KP; Madsen KL; Reimer RA
BMC Gastroenterol; 2015 Dec; 15():169. PubMed ID: 26635079
[TBL] [Abstract][Full Text] [Related]
24. Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives.
Hu H; Lin A; Kong M; Yao X; Yin M; Xia H; Ma J; Liu H
J Gastroenterol; 2020 Feb; 55(2):142-158. PubMed ID: 31845054
[TBL] [Abstract][Full Text] [Related]
25. Non-Alcoholic Fatty Liver Disease Treatment in Patients with Type 2 Diabetes Mellitus; New Kids on the Block.
Athyros VG; Polyzos SA; Kountouras J; Katsiki N; Anagnostis P; Doumas M; Mantzoros CS
Curr Vasc Pharmacol; 2020; 18(2):172-181. PubMed ID: 30961499
[TBL] [Abstract][Full Text] [Related]
26. Role of the Gut Microbiota in Regulating Non-alcoholic Fatty Liver Disease in Children and Adolescents.
Tokuhara D
Front Nutr; 2021; 8():700058. PubMed ID: 34250000
[TBL] [Abstract][Full Text] [Related]
27. Fructose: A Dietary Sugar in Crosstalk with Microbiota Contributing to the Development and Progression of Non-Alcoholic Liver Disease.
Lambertz J; Weiskirchen S; Landert S; Weiskirchen R
Front Immunol; 2017; 8():1159. PubMed ID: 28970836
[TBL] [Abstract][Full Text] [Related]
28. The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies.
Meroni M; Longo M; Dongiovanni P
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31689910
[TBL] [Abstract][Full Text] [Related]
29. Identification of a novel probiotic and its protective effects on NAFLD via modulating gut microbial community.
Geng W; Zhang Y; Yang J; Zhang J; Zhao J; Wang J; Jia L; Wang Y
J Sci Food Agric; 2022 Aug; 102(11):4620-4628. PubMed ID: 35174500
[TBL] [Abstract][Full Text] [Related]
30. Microbial Intervention as a Novel Target in Treatment of Non-Alcoholic Fatty Liver Disease Progression.
Zhou Y; Zheng T; Chen H; Li Y; Huang H; Chen W; Du Y; He J; Li Y; Cao J; Nie Y; Zhou Y
Cell Physiol Biochem; 2018; 51(5):2123-2135. PubMed ID: 30522122
[TBL] [Abstract][Full Text] [Related]
31. Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications.
Fang J; Yu CH; Li XJ; Yao JM; Fang ZY; Yoon SH; Yu WY
Front Cell Infect Microbiol; 2022; 12():997018. PubMed ID: 36425787
[TBL] [Abstract][Full Text] [Related]
32. Interaction between mucus layer and gut microbiota in non-alcoholic fatty liver disease: Soil and seeds.
Zhang B; Li J; Fu J; Shao L; Yang L; Shi J
Chin Med J (Engl); 2023 Jun; 136(12):1390-1400. PubMed ID: 37200041
[TBL] [Abstract][Full Text] [Related]
33. Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications.
Chen J; Vitetta L
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32717871
[TBL] [Abstract][Full Text] [Related]
34. Increased plasma genistein after bariatric surgery could promote remission of NAFLD in patients with obesity.
Wang G; Wang Y; Bai J; Li G; Liu Y; Deng S; Zhou R; Tao K; Xia Z
Front Endocrinol (Lausanne); 2022; 13():1024769. PubMed ID: 36686492
[TBL] [Abstract][Full Text] [Related]
35. Non-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapies.
Ebrahimzadeh Leylabadlo H; Ghotaslou R; Samadi Kafil H; Feizabadi MM; Moaddab SY; Farajnia S; Sheykhsaran E; Sanaie S; Shanehbandi D; Bannazadeh Baghi H
Eur J Clin Microbiol Infect Dis; 2020 Apr; 39(4):613-627. PubMed ID: 31828683
[TBL] [Abstract][Full Text] [Related]
36. Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?
Xie C; Halegoua-DeMarzio D
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31752378
[TBL] [Abstract][Full Text] [Related]
37. Gut-liver axis, nutrition, and non-alcoholic fatty liver disease.
Kirpich IA; Marsano LS; McClain CJ
Clin Biochem; 2015 Sep; 48(13-14):923-30. PubMed ID: 26151226
[TBL] [Abstract][Full Text] [Related]
38. Functional changes of the gastric bypass microbiota reactivate thermogenic adipose tissue and systemic glucose control via intestinal FXR-TGR5 crosstalk in diet-induced obesity.
Münzker J; Haase N; Till A; Sucher R; Haange SB; Nemetschke L; Gnad T; Jäger E; Chen J; Riede SJ; Chakaroun R; Massier L; Kovacs P; Ost M; Rolle-Kampczyk U; Jehmlich N; Weiner J; Heiker JT; Klöting N; Seeger G; Morawski M; Keitel V; Pfeifer A; von Bergen M; Heeren J; Krügel U; Fenske WK
Microbiome; 2022 Jun; 10(1):96. PubMed ID: 35739571
[TBL] [Abstract][Full Text] [Related]
39. Contribution of gut microbiota to nonalcoholic fatty liver disease: Pathways of mechanisms.
Bakhshimoghaddam F; Alizadeh M
Clin Nutr ESPEN; 2021 Aug; 44():61-68. PubMed ID: 34330514
[TBL] [Abstract][Full Text] [Related]
40. Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese Mice.
de Sant'Ana LP; Ribeiro DJS; Martins AMA; Dos Santos FN; Corrêa R; Almeida RDN; Eberlin MN; Maurice CF; Magalhães KG
Front Immunol; 2019; 10():2926. PubMed ID: 31998283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
